CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-26 | Davis J. E. EVP, General Diagnostics | Shares withheld for taxes | −1,432 | $87.84 | $126K | 40,096 |
| 2019-02-26 | Cunningham Everett SVP, Commercial | Shares withheld for taxes | −1,112 | $87.84 | $98K | 39,755 |
| 2019-02-26 | Cunningham Everett SVP, Commercial | Sale | −352 | $87.06 | $31K | 39,403 |
| 2019-02-25 | RUSCKOWSKI STEPHEN H Chairman, President and CEO | Shares withheld for taxes | −2,318 | $88.24 | $205K | 204,082 |
| 2019-02-25 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −315 | $88.24 | $28K | 42,108 |
| 2019-02-25 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −336 | $88.23 | $30K | 41,772 |
| 2019-02-25 | Klug Robert A VP, Corporate Controller | Shares withheld for taxes | −52 | $88.24 | $5K | 5,435 |
| 2019-02-25 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −660 | $88.24 | $58K | 62,125 |
| 2019-02-25 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −363 | $88.24 | $32K | 22,793 |
| 2019-02-25 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −363 | $88.24 | $32K | 70,590 |
| 2019-02-25 | Davis J. E. EVP, General Diagnostics | Shares withheld for taxes | −547 | $88.24 | $48K | 41,528 |
| 2019-02-25 | Cunningham Everett SVP, Commercial | Shares withheld for taxes | −431 | $88.24 | $38K | 41,193 |
| 2019-02-25 | Cunningham Everett SVP, Commercial | Sale | −326 | $88.23 | $29K | 40,867 |
| 2019-02-22 | WILENSKY GAIL R Director | Exercise or conversion | +8,000 | $51.55 | $412K | 34,604 |
| 2019-02-22 | WILENSKY GAIL R Director | Sale | −8,000 | $87.78 | $702K | 26,604 |
| 2019-02-22 | WILENSKY GAIL R Director | Exercise or conversion · Stock Options (Right to Buy) | −8,000 | $51.55 | $412K | 0 |
| 2018-03-01 | Cunningham Everett SVP, Commercial | Gift | −491 | $104.78 | $51K | 37,760 |
| 2011-01-31 | GLAXOSMITHKLINE PLC Director | Sale | −15,377,600 | $55.62 | $855.2M | 15,377,551 |
| 2011-01-31 | GLAXOSMITHKLINE PLC Director | Sale | −15,377,551 | $54.30 | $835.0M | 0 |
| 2009-03-19 | GLAXOSMITHKLINE PLC Director | Sale | −230,295 | $44.36 | $10.2M | 35,274,013 |
Page 50 of 52 · 1,040 trades